Stay updated on HOPE-B: AMT-061 Clinical Trial

Sign up to get notified when there's something new on the HOPE-B: AMT-061 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HOPE-B: AMT-061 Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision tag has been updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:53:35.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added new data points and definitions for outcomes and safety, including Month 60 AFP levels, inflammatory markers, anti-AAV5 antibodies, vector DNA shedding, adverse events, and multiple FIX activity and bleeding endpoints with specified timepoints. Deleted older endpoints and measurement definitions (for example ABR calculation method, lead-in FIX consumption and activity metrics, and some lead-in/18-month timepoints) to align with updated study reporting.
    Difference
    3%
    Check dated 2026-03-29T03:56:15.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Updated the site revision from v3.4.3 to v3.5.0; the page content and user workflows remain unchanged.
    Difference
    0.0%
    Check dated 2026-03-21T20:25:52.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2. The update does not modify study information, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-03-07T13:07:43.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.4.2, replacing Revision: v3.4.1. This appears to be a minor system update with no impact on study content or user actions.
    Difference
    0.0%
    Check dated 2026-02-13T17:23:42.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Publications section updated: added the NEJM article 'Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B' (N Engl J Med, 2026 Jan 29; DOI 10.1056/NEJMoa2514332) and removed the NEJM article 'Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B' (Dec 7, 2025).
    Difference
    0.1%
    Check dated 2026-02-06T11:16:33.000Z thumbnail image

Stay in the know with updates to HOPE-B: AMT-061 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HOPE-B: AMT-061 Clinical Trial page.